INBX
Inhibrx Biosciences, Inc.
99.60$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +25.9% | +2.4% | +5.8% | +40.9% | -44.4% | -69.2% | -17.9% | -88.9% | +550.0% | |
| – | +50.1% | +31.1% | +43.2% | +53.4% | -96.3% | +3,999.2% | -98.9% | +91.9% | +8.7% | |
| – | – | – | – | – | – | -2,533.9% | – | -442.4% | – | |
| – | +50.1% | +31.1% | +43.2% | +53.4% | -2.8% | +54.2% | +73.0% | +6.9% | -44.5% | |
| – | +43.3% | +78.4% | +93.8% | -24.2% | +80.7% | +71.0% | +39.1% | +335.3% | -81.8% | |
| – | +49.1% | -83.4% | +120.0% | +695.6% | +1.1% | -74.0% | +940.8% | +49.8% | -59.4% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | -30.4% | +286.4% | +89.1% | -51.8% | +208.8% | +97.7% | -57.6% | -9.6% | |
| – | – | – | – | – | – | – | – | – | -108.3% | |
| – | – | -61.6% | +835.4% | -99.7% | -33.3% | +50.0% | +0.0% | -33.3% | +0.0% | |
| – | – | – | – | – | – | – | – | – | -108.3% | |
| – | – | – | – | – | – | – | – | – | -107.4% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.